Rare genetic epilepsy

Rare genetic epilepsy (Orphanet code 183512) is a broad classification encompassing a heterogeneous group of epileptic disorders caused by identifiable genetic mutations. These conditions are characterized by recurrent seizures resulting from abnormal electrical activity in the brain, where the underlying cause is a pathogenic variant in one or more genes involved in neuronal development, ion channel function, synaptic transmission, or other critical neurological pathways. The central nervous system is the primary body system affected, though many rare genetic epilepsies also impact cognitive development, motor function, behavior, and in some cases other organ systems. Key clinical features vary widely depending on the specific genetic etiology but commonly include seizures of various types (focal, generalized, or both), developmental delay or intellectual disability, electroencephalographic (EEG) abnormalities, and in many cases drug-resistant epilepsy. Some forms present in the neonatal or infantile period with severe epileptic encephalopathy, while others may manifest later in childhood or adolescence. Associated features may include movement disorders, behavioral disturbances, regression of developmental milestones, and in certain subtypes, structural brain abnormalities. The treatment landscape for rare genetic epilepsies includes antiseizure medications, which remain the mainstay of therapy, though many patients experience pharmacoresistant seizures. Specific therapies may be available for certain genetic subtypes, such as the ketogenic diet for GLUT1 deficiency syndrome, or targeted therapies like quinidine for KCNT1-related epilepsy. Emerging precision medicine approaches, including gene therapy and antisense oligonucleotides, are under active investigation for several rare genetic epilepsies. Multidisciplinary management involving neurology, genetics, developmental pediatrics, and rehabilitation services is essential for optimizing outcomes.

Common questions about Rare genetic epilepsy